Contact US

NeoMed Awarded New Multi-Year Group Purchasing Contracts by Vizient

NeoMed® a leading inno­vator of ENFit® prod­ucts and acces­sories for use in multiple care envi­ron­ments, is pleased to announce they have been awarded two new agree­ments by Vizient, Inc., the largest member-driven health care perfor­mance improve­ment company in the country. These new multi-year agree­ments provide Vizient’s diverse member­ship base the oppor­tu­nity to access NeoMed prod­ucts at optimal pricing with enhanced contract terms.

The vast port­folio avail­able on these contracts includes both NeoMed’s NeoConnect® with ENFit Connectors and Legacy prod­ucts. The NeoConnect product offering includes enteral syringes, phar­macy syringes, sampling straws, transfer lids, NeoSecure® tip caps, exten­sion sets, and feeding tubes in polyurethane, sili­cone, and polyvinyl chlo­ride (PVC).

Additionally, the Legacy product offering includes oral/enteral syringes, sampling straws, sterile and bulk-packaged phar­macy syringes, self-righting tip caps, transfer lids, exten­sion sets, and feeding tubes in polyurethane, sili­cone, and PVC.

“The award of these two new agree­ments demon­strates NeoMed’s commit­ment to deliver high-quality prod­ucts, while supporting our customers’ cost-containment objec­tives. As our product reach expands to the whole hospital, we are very proud to offer enhanced savings to our evolving customer base,” stated Vice President of Business Development, Marc Waldman.

For ordering infor­ma­tion, contact your local NeoMed sales repre­sen­ta­tive, visit, or call 888-876-2225.


About NeoMed, Inc.

Founded in 2007, NeoMed develops inno­v­a­tive enteral collec­tion and delivery prod­ucts supporting the special­ized feeding and medica­tion dosing needs of the low birth weight, neonatal, and pedi­atric patients. With more than 140 successful ENFit tran­si­tions repre­senting over 10 million admin­is­tered feed and medica­tion doses, NeoMed is committed to improve patient outcomes through product designs that meet safety, clin­ical, and regu­la­tory guide­lines while supporting cost- contain­ment objec­tives.